JAK1 and viral infectious disease: NF-κB inhibitors (JSH-23 and QNZ), JAK1 inhibitor itacitinib, and Ifnar1 deficiency blocked viral infection-induced DTX3L expression (Fig. S3h–p), suggesting that viruses activate NF-κB and IFNAR-JAK to upregulate DTX3L.